Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes. (2017)
Attributed to:
Understanding cell fate decisions in normal and abnormal haematopoiesis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2017.06.067
PubMed Identifier: 28723562
Publication URI: http://europepmc.org/abstract/MED/28723562
Type: Journal Article/Review
Volume: 20
Parent Publication: Cell reports
Issue: 3